These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6355319)

  • 1. Pathogenesis of Shigella diarrhea. VIII. Evidence for a translocation step in the cytotoxic action of Shiga toxin.
    Jacewicz M; Keusch GT
    J Infect Dis; 1983 Nov; 148(5):844-54. PubMed ID: 6355319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shigella toxin and the pathogenesis of shigellosis.
    Keusch GT; Donohue-Rolfe A; Jacewicz M
    Ciba Found Symp; 1985; 112():193-214. PubMed ID: 3847336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocytosis from coated pits of Shiga toxin: a glycolipid-binding protein from Shigella dysenteriae 1.
    Sandvig K; Olsnes S; Brown JE; Petersen OW; van Deurs B
    J Cell Biol; 1989 Apr; 108(4):1331-43. PubMed ID: 2564398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity of Shigella dysenteriae 1 for cultured mammalian cells.
    Hale TL; Formal SB
    Am J Clin Nutr; 1980 Nov; 33(11 Suppl):2485-90. PubMed ID: 7001884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary amines and chloroquine inhibit cytotoxic responses to Shigella toxin and permit late antibody rescue of toxin treated cells.
    Keusch GT; Jacewicz M
    Biochem Biophys Res Commun; 1984 May; 121(1):69-76. PubMed ID: 6428408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of Shigella diarrhea: XVII. A mammalian cell membrane glycolipid, Gb3, is required but not sufficient to confer sensitivity to Shiga toxin.
    Jacewicz MS; Mobassaleh M; Gross SK; Balasubramanian KA; Daniel PF; Raghavan S; McCluer RH; Keusch GT
    J Infect Dis; 1994 Mar; 169(3):538-46. PubMed ID: 8158025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of Shigella diarrhea. XIV. Analysis of Shiga toxin receptors on cloned HeLa cells.
    Jacewicz M; Feldman HA; Donohue-Rolfe A; Balasubramanian KA; Keusch GT
    J Infect Dis; 1989 May; 159(5):881-9. PubMed ID: 2651533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemical and cytotoxic activities of Shigella dysenteriae 1 (shiga) and shiga-like toxins.
    O'Brien AD; Laveck GD
    Infect Immun; 1982 Mar; 35(3):1151-4. PubMed ID: 7040247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct cytotoxic action of Shiga toxin on human vascular endothelial cells.
    Obrig TG; Del Vecchio PJ; Brown JE; Moran TP; Rowland BM; Judge TK; Rothman SW
    Infect Immun; 1988 Sep; 56(9):2373-8. PubMed ID: 3044997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of Shiga toxin and other cytotoxins by serogroups of Shigella.
    Bartlett AV; Prado D; Cleary TG; Pickering LK
    J Infect Dis; 1986 Dec; 154(6):996-1002. PubMed ID: 3537154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Entry of Shigella dysenteriae toxin into HeLa cells.
    Eiklid K; Olsnes S
    Infect Immun; 1983 Nov; 42(2):771-7. PubMed ID: 6358031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells.
    Tesh VL; Samuel JE; Perera LP; Sharefkin JB; O'Brien AD
    J Infect Dis; 1991 Aug; 164(2):344-52. PubMed ID: 1649877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of the Shiga toxin gene in a chlorate-resistant derivative of Shigella dysenteriae type 1 that retains virulence.
    Neill RJ; Gemski P; Formal SB; Newland JW
    J Infect Dis; 1988 Oct; 158(4):737-41. PubMed ID: 3049838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography.
    O'Brien AD; LaVeck GD; Griffin DE; Thompson MR
    Infect Immun; 1980 Oct; 30(1):170-9. PubMed ID: 7002787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shiga toxin: purification, structure, and function.
    Donohue-Rolfe A; Acheson DW; Keusch GT
    Rev Infect Dis; 1991; 13 Suppl 4():S293-7. PubMed ID: 2047652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of three amino acid residues in the B subunit of Shiga toxin and Shiga-like toxin type II that are essential for holotoxin activity.
    Perera LP; Samuel JE; Holmes RK; O'Brien AD
    J Bacteriol; 1991 Feb; 173(3):1151-60. PubMed ID: 1991714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shiga toxin from Shigella dysenteriae 1 inhibits protein synthesis in reticulocyte lysates by inactivation of aminoacyl-tRNA binding.
    Brown JE; Obrig TG; Ussery MA; Moran TP
    Microb Pathog; 1986 Aug; 1(4):325-34. PubMed ID: 3334156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of functional Shiga toxin subunits and renatured holotoxin.
    Donohue-Rolfe A; Jacewicz M; Keusch GT
    Mol Microbiol; 1989 Sep; 3(9):1231-6. PubMed ID: 2677606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide.
    Jacewicz M; Clausen H; Nudelman E; Donohue-Rolfe A; Keusch GT
    J Exp Med; 1986 Jun; 163(6):1391-404. PubMed ID: 3519828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shiga toxin induces medullary tubular injury in isolated perfused rat kidneys.
    Shibolet O; Shina A; Rosen S; Cleary TG; Brezis M; Ashkenazi S
    FEMS Immunol Med Microbiol; 1997 May; 18(1):55-60. PubMed ID: 9215587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.